About Wainamics
Integrating Your Biology To Microfluidic Cartridges
At Wainamics, we specialize in the design, development, and manufacturing of microfluidic cartridges and related systems, serving the life sciences and diagnostics industries. Since our founding in 2014 in the Bay Area, we have been dedicated to empowering our clients with innovative solutions that simplify complex processes and enable groundbreaking advancements in healthcare and technology.
Our team of seasoned professionals combines deep expertise in microfluidics, engineering, and product development to deliver custom solutions tailored to the unique needs of each client. From initial concept design to final production, we provide end-to-end support, ensuring precision, efficiency, and quality at every step.
Wainamics is built on a foundation of collaboration and innovation. We pride ourselves on being a trusted partner, helping our clients bring their visions to life through unparalleled service and technical excellence.
Specialties include, system architecture and early-stage design, bioassay performance verification and optimization on cartridge, consumable cartridge rapid prototyping, design for manufacturing, design for assembly, manufacturing strategic planning and manufacturing transfer.
Mission
Our mission is to provide life science research and diagnostic companies exceptional service and product development expertise.
We want to enable our customers to successfully launch products at an accelerated pace — with the ultimate goal of improving healthcare.

We’ve helped 50+ organizations with 100+ projects — from startups to large companies and government agencies.

Timeline
2014Wainamics Incorporation
2015First Patent on Blood Separation
2017Factor VIII Coagulation Platform
2018Move to Pleasanton, CA
2000 sqft lab2019Ignite $27m Series A
2020Molecular Test Platform
$2m RADx funding and AmplifiDx Spinoff2021Collaboration with Jennifer Doudna at IGI
$2m RADx funding and AmplifiDx Spinoff2021Move to 7026 Koll Center
4000 sqft2023NASA SBIR Phase I & II, $1m
Cell Perfusion System2023PCR STD Chip
202410th Year Anniversary
100+ Project | 50+ Companies